NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Cannabis doubles car crash risk
Fri February 10th - Cannabis users who drive within three hours of taking the drug are at double the risk of crashing than those who are not under the influence of alcohol or drugs, researchers said today. More
Planned caesarean carries lowest severe bleeding risk
Fri February 10th - Severe bleeding after giving birth is much less likely with a planned caesarean, Danish researchers have found. More
THIS WEEK'S STORIES
Gene therapy gives sight to blind
Thurs February 9th - A gene therapy treatment for people with congenital blindness has now been used to give sight to both eyes, researchers announced last night. More
One in five male Brits has heart gene
Thurs February 9th - Families sometimes wonder why their men seem prone to heart disease - and new research today suggests the answer is genetic. More
Obesity drugs backed
Thurs February 9th - Anti-obesity drugs can make a major difference in helping assist people to lose weight when they make lifestyle changes, according to British researchers. More
Antiseptic on umbilical cord fights infection
Wed February 8th - Cleaning a newborn's umbilical cord at birth can help to limit infections, experts say today. More
Age - a risk factor for breast cancer death
Wed February 8th - Older women with breast cancer face a greater risk of succumbing to the disease than younger women, according to a Dutch study published today. More
ENGLEMED HEALTH NEWS

Hope for Hawking disease

Thursday July 15th, 2010

Medical school researchers have found a protein that may form the basis of treatment for muscle-wasting diseases.

Researchers believe the protein plays a key role in the nerves that control the muscles.

It is the decay of these nerves that causes conditions such as motor-neurone disease, the disease which afflicts astronomer Professor Stephen Hawking.

The research at Aberdeen University has shown the protein TGFb2 asks like a signal-booster that improves television pictures by amplifying messages in the nerves.

Senior lecturer Dr Guy Bewick has worked with scientists at the University of Otago, New Zealand, on the project, reported in the Proceedings of the National Academy of Sciences.

He said: "We knew this protein was in muscle cells near the motor nerve endings. It plays key roles elsewhere in the body, including the brain, controlling development or damage and infection responses, but we didn't understand what it did in normal, adult, healthy muscles.

"Our finding gives us a better understanding of how our nerve endings maintain the correct signalling strength as we grow, or take on new activities, like running or weight training.

"It could also point to new ways of treating symptoms of reduced nerve-muscle signalling, such as weakness and tiredness in early stages of motor neurone disease, when failing nerve endings might be boosted enough to work for longer."

He said that injecting the protein into humans would be "highly toxic" but the findings could lead to the development of drugs.

Tags: Australia | Brain & Neurology | UK News

Printer friendly page Printer friendly page

CATEGORIES